The allosteric AKT inhibitor, MK-2206, and γ-tocotrienol can down-regulate AKT/mTOR signaling activity, then induce cell cycle arrest in the G0/G1 phase of the cell cycle, cause apoptosis and reduce tumor growth [37,38]. The gene discussed is AKT1; the disease is neoplasm.